Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL ANTI-IL-36R ANTIBODIES
Document Type and Number:
WIPO Patent Application WO/2023/072182
Kind Code:
A1
Abstract:
Provided are anti-IL-36R antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same and the uses thereof.

Inventors:
FAN PENGCHENG (CN)
LEI RUN (CN)
GUO CHONGTIAN (CN)
FAN LIHUA (CN)
SUN QIANG (CN)
XU ZHIHAO (CN)
Application Number:
PCT/CN2022/127898
Publication Date:
May 04, 2023
Filing Date:
October 27, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
INMAGENE BIOPHARMACEUTICALS HANGZHOU CO LTD (CN)
INMAGENE PTE LTD (SG)
International Classes:
C07K16/28; A61K35/17; A61K39/395; C07K19/00; C12N5/10; G01N33/68
Domestic Patent References:
WO2021132638A12021-07-01
Foreign References:
US20200017592A12020-01-16
CN112094349A2020-12-18
US20180273627A12018-09-27
CN107847590A2018-03-27
Other References:
ZHU, C.; WEN, JU; LI, TING; QIN, SI: "Effects of IL-36 Antibody on Skin of Mouse Psoriasis Induced by Imiquimod and the Expression of CCL20", THE CHINESE JOURNAL OF DERMATOVENEREOLOGY, XI'AN JIAOTONG DAXUE, XI'AN, CN, vol. 31, no. 3, 31 March 2017 (2017-03-31), CN , pages 246 - 250, XP009545910, ISSN: 1001-7089, DOI: 10.13735/j.cjdv.1001-7089.201609093
Attorney, Agent or Firm:
JUN HE LAW OFFICES (CN)
Download PDF: